GITA MAKKAR: Open Payments
NPI 1922338631 · NEW CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 68 payments from 13 companies in 2025. Trend: 2023 $1,823 · 2024 $2,237 · 2025 $1,395
Food & beverage: $1,204Education: $191
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $355 |
| Arcutis Biotherapeutics, Inc. | 10 | $224 |
| ABBVIE INC. | 15 | $194 |
| Janssen Biotech, Inc. | 4 | $156 |
| Organon LLC | 10 | $146 |
| Amgen Inc. | 6 | $107 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Almirall LLC | 2 | $39 |
| Botanix SB Inc | 2 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
Products named: DUPIXENT, Zoryve, TREMFYA, OTEZLA, SKYRIZI, DALVANCE, VTAMA, Sotyktu.
Industry payments across NY — which companies pay providers there.
